MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the

Xizhe Li1, Jiali Zhu2, Yuanqi Liu1

  • 1Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.

Cancer Science
|April 8, 2019
PubMed

Insights

MicroRNA-331-3p is downregulated in non-small-cell lung cancer (NSCLC), suppressing tumor cell migration and metastasis. This microRNA targets ErbB2 and VAV2, impacting the Rac1/PAK1/β-catenin pathway and serving as a prognostic marker for NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs regulate non-small-cell lung cancer (NSCLC) development.
  • The specific role of microRNA (miR)-331-3p in NSCLC remains largely undetermined.
  • Understanding miR-331-3p's function is crucial for identifying novel therapeutic targets and prognostic markers in NSCLC.

Purpose of the Study:

  • To investigate the expression levels and clinical significance of miR-331-3p in NSCLC.
  • To elucidate the role of miR-331-3p in regulating NSCLC cell epithelial-mesenchymal transition (EMT), migration, and metastasis.
  • To identify the direct targets and downstream pathways modulated by miR-331-3p in NSCLC.

Main Methods:

  • Quantitative RT-PCR to assess miR-331-3p expression in NSCLC tissues.
  • In vitro and in vivo assays to evaluate the effects of miR-331-3p on cell migration and metastasis.
  • Luciferase reporter assays, Western blot, and immunohistochemistry to identify direct targets.
  • Immunofluorescence, immunoprecipitation, and Rac1 activity assays to determine the downstream pathway.

Main Results:

  • miR-331-3p was significantly downregulated in NSCLC tissues and correlated with clinicopathological characteristics.
  • Downregulation of miR-331-3p was associated with poorer prognosis, identifying it as an independent prognostic marker.
  • miR-331-3p suppressed EMT, migration, and metastasis of NSCLC cells both in vitro and in vivo.
  • ErbB2 and VAV2 were identified as direct targets of miR-331-3p.
  • miR-331-3p regulated the activities of Rac1, PAK1, and β-catenin through targeting ErbB2 and VAV2.

Conclusions:

  • miR-331-3p acts as a tumor suppressor in NSCLC by inhibiting EMT, migration, and metastasis.
  • The tumor-suppressive function of miR-331-3p is mediated through the targeting of ErbB2 and VAV2, subsequently affecting the Rac1/PAK1/β-catenin signaling axis.
  • miR-331-3p holds potential as a valuable prognostic biomarker for NSCLC patients.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.1K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Phase Transitions02:31

Phase Transitions

Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
22.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
Properties of Transition Metals02:58

Properties of Transition Metals

Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals.
29.7K